""
Skip to content

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.

  • Instead of running on average three tests per
    patient, they now only run one and get a
    comprehensive analysis
  • The workflow is fast and simple; with just one
    tube we can test most of the thalassemias
    almost 100%
  • They can save on average 4 weeks for a patient
    waiting for their diagnosis

Get access to the case study by filling out the form below

Whitepaper

Which is the best approach for CFTR diagnosis: Targeted NGS or Whole Exome Sequencing?

Discover the most effective approach for accurate CFTR gene analysis with our new whitepaper. Learn how laboratories can achieve superior variant detection and consistent coverage, while streamlining workflows and turnaround times.

This whitepaper explores the analytical and operational factors behind choosing targeted NGS for CFTR diagnosis. See how the Devyser CFTR assay delivers comprehensive variant coverage, integrated CNV detection, and rapid results in a single day workflow, helping laboratories deliver precise and reliable results with confidence.